Weihai Baihe Biology Technological Co., Ltd.

SHSE:603102 Stock Report

Market Cap: CN¥2.1b

Weihai Baihe Biology Technological Balance Sheet Health

Financial Health criteria checks 6/6

Weihai Baihe Biology Technological has a total shareholder equity of CN¥1.6B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.8B and CN¥178.2M respectively. Weihai Baihe Biology Technological's EBIT is CN¥153.0M making its interest coverage ratio -10.6. It has cash and short-term investments of CN¥1.1B.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-10.6x
CashCN¥1.08b
EquityCN¥1.58b
Total liabilitiesCN¥178.24m
Total assetsCN¥1.76b

Recent financial health updates

No updates

Recent updates

Weihai Baihe Biology Technological (SHSE:603102) Could Be Struggling To Allocate Capital

Oct 01
Weihai Baihe Biology Technological (SHSE:603102) Could Be Struggling To Allocate Capital

Financial Position Analysis

Short Term Liabilities: 603102's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥160.6M).

Long Term Liabilities: 603102's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥17.6M).


Debt to Equity History and Analysis

Debt Level: 603102 is debt free.

Reducing Debt: 603102 has not had any debt for past 5 years.

Debt Coverage: 603102 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 603102 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies